EMERGING TREATMENTS IN MULTIPLE-SCLEROSIS

Currently used and developing therapies for multiple sclerosis (MS) ar e dealing with the treatment of acute exacerbations, the prevention of relapses and of the progression of neurological handicap, the treatme nt of symptoms, and the repair of demyelinated lesions. New insights i nto the treatment of acute relapses as well as recent immunomodulatory and immunosuppressive agents tested in MS are exposed in this brief r eview. Interferon-beta (1a and 1b), copolymer 1 and new immunosuppress ive therapies are particularly discussed with emphasis on their potent ial to alter the course of MS.